First drug for severe form of fatty liver disease approved

Fatty liver disease, hepatic steatosis, NAFLD, NASH, liver cirrhosis, FDA approves Rezdiffra, Madrigal Pharmaceuticals, liver scarring, Nikolay Nikolov. Disease linked to obesity, high cholesterol, diabetes, alcohol abuse, with medication focusing on liver damage treatment.